{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:40Z","timestamp":1762505380551,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4743,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.fertnstert.2008.03.082","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T04:23:56Z","timestamp":1213849436000},"page":"2527-2536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome"],"prefix":"10.1016","volume":"91","clinical-trial-number":[{"clinical-trial-number":"nct00428311","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Covadonga","family":"Mendieta-Azcona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"\u00c1lvarez-Blasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2008.03.082_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib2","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2007-0190","article-title":"Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00125-003-1090-z","article-title":"Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women","volume":"46","author":"Escobar-Morreale","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib6","first-page":"66","article-title":"Glucose Intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and \u03b2-cell dysfunction and risk of cardiovascular disease","volume":"86","author":"Arslanian","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib7","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome (PCOS)","volume":"22","author":"Luque-Ramirez","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib9","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1472-6483(10)60928-5","article-title":"Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?","volume":"8","author":"Cheang","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib11","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"1","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib12","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ramirez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib13","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","volume":"Vol. 4","author":"Zawadzki","year":"1992"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00004872-199512000-00003","article-title":"Ambulatory blood pressure normality: results from the PAMELA study","volume":"13","author":"Mancia","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.CIR.74.6.1399","article-title":"Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging","volume":"74","author":"Pignoli","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib17","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib18","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002966.pub3","article-title":"Metformin monotherapy for type 2 diabetes mellitus","volume":"3","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib20","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2265.2007.02985.x","article-title":"The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"67","author":"Sahin","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib22","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00004872-199715100-00003","article-title":"Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994","volume":"15","author":"Dong","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib23","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib24","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11906-006-0080-1","article-title":"Estrogen and hypertension","volume":"8","author":"Ashraf","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2125.2006.02747.x","article-title":"de Jong-van den Berg LT. The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate","volume":"63","author":"Atthobari","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1542-474X.2006.00122.x","article-title":"Heart rate variability in young women with polycystic ovary syndrome","volume":"11","author":"Yildirir","year":"2006","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.metabol.2006.09.006","article-title":"Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome","volume":"56","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/hy1201.097300","article-title":"Vascular smooth muscle cell activation by glycated albumin (Amadori adducts)","volume":"39","author":"Hattori","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib31","doi-asserted-by":"crossref","first-page":"445.e1","DOI":"10.1016\/j.ahj.2006.11.005","article-title":"A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes","volume":"153","author":"Stocker","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib32","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1210\/jc.2005-0965","article-title":"Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study","volume":"90","author":"Orio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.01840","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome","volume":"152","author":"Rautio","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2008.03.082_bib34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","article-title":"Insulin-lowering agents in the management of polycystic ovary syndrome","volume":"24","author":"de Leo","year":"2003","journal-title":"Endocr Rev"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208007814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028208007814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:30:57Z","timestamp":1758007857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028208007814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0015028208007814"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.03.082","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2008.03.082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}